BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19924440)

  • 1. Borderline and malignant phyllodes tumors display similar promoter methylation profiles.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2009 Dec; 455(6):469-75. PubMed ID: 19924440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.
    Do SI; Kim JY; Kang SY; Lee JJ; Lee JE; Nam SJ; Cho EY
    Tumour Biol; 2013 Feb; 34(1):445-53. PubMed ID: 23150175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
    Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
    Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
    Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
    Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
    Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
    J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
    Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.
    Vu TL; Nguyen TT; Doan VTH; Vo LTT
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1887-1893. PubMed ID: 30049201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.
    Lee JS
    Virchows Arch; 2007 Jun; 450(6):637-42. PubMed ID: 17479284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
    Cho YH; Shen J; Gammon MD; Zhang YJ; Wang Q; Gonzalez K; Xu X; Bradshaw PT; Teitelbaum SL; Garbowski G; Hibshoosh H; Neugut AI; Chen J; Santella RM
    Breast Cancer Res Treat; 2012 Jan; 131(1):197-205. PubMed ID: 21837480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
    Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
    J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
    Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
    Lee JS; Lo PK; Fackler MJ; Argani P; Zhang Z; Garrett-Meyer E; Sukumar S
    Cancer Biol Ther; 2007 Jul; 6(7):1114-20. PubMed ID: 17611401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.
    Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P
    Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
    Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
    J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
    Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.